The accuracy of women performing vaginal pH self-testing

Journal of Women's Health

Volumn 17, Issue 4, 2008, Pages 523-526

  Kulp, Jennifer L ^a   Chaudhry, Sonal ^a   Wiita, Brinda ^b   Bachmann, Gloria ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; NON PRESCRIPTION DRUG;

ACCURACY; ADULT; AGED; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PH MEASUREMENT; PHYSICIAN; PRIORITY JOURNAL; SELF EXAMINATION; VAGINA SMEAR;

ADMINISTRATION, INTRAVAGINAL; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; DNA, VIRAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYDROGEN-ION CONCENTRATION; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; SELF CARE; SELF MEDICATION; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; UNITED STATES; VAGINAL SMEARS; VAGINITIS;

EID: 43049088142     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2007.0446     Document Type: Article

References (19)

1. Paavonen J, Stamm WE. Lower genital tract infections in women. Infect Dis Clin North Am 1987;1:179.
2. Sparks JM. Vaginitis. J Reprod Med 1991;36:745-752.
3. McCormack WM Jr, Zinner SH, McCormack WM. The incidence of genitourinary infections in a cohort of healthy women. Sex Transm Dis 1994;21:63.
4. Hurley R, Delouvois J. Candida vaginitis. Post Grad Med 1979;55:645.
5. Foxman R, Barlow H, D'Arcy B, Gillespie, Sobel JD. Candida vaginitis: Self-reported incidence and associated costs. Sex Transm Dis 2000;27:230.
6. FDA Drug and Device approvals. Available at www.fda.gov
7. Ferris DG, Dekle C, Litaker MS. Women's use of over-the-counter antifungal pharmaceutical products for gynecologic symptoms. J Fam Pract 1996;42:595.
8. Ferris DG, Nyirjesy P, Sobel JD, et al. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 2002;99:419.
9. Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidias: Epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998;178:203.
10. Korn AP, Bolan G, Pardian N, Ohm-Smith M, Schacter J, Landers DV. Plasma cell endometritis in women with symptomatic bacterial vaginosis. Obstet Gynecol 1995;85:387.
11. Faro S, Martens M, Maccato M, Hammill H, Pearlman M. Vaginal flora and pelvic inflammatory disease. Am J Obstet Gynecol 1993;169:470.
12. Sewankambo N, Gray RH, Wawer MJ, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997;350:546.
13. Tara TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora association with increased acquisition of HIV. AIDS 1998;12:1699.
14. Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999;180:1863.
15. McGinn T, Wyer PC, Newman TB, Keitz S, Leipzig R, Guyatt G, for the Evidence-Based Medicine Teaching Tips Working Group. Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). Can Med Assoc J 2004;171:1369.
16. Roy S, Caillouette JC, Faden JS, Roy T, Ramon DE. Improving appropriate use of antifungal medications: The role of an over-the-counter vaginal pH self-test device. Infect Dis Obstet Gynecol 2003;11:209.
17. Roy S, Caillouette JC, Faden JS, Roy T. The role of an over-the-counter vaginal pH self-test device package insert: Can subjects learn what the device is for and how to use it? Am J Obstet Gynecol 2005;192:1963.
18. Ferris DG, Francis SL, Dickman ED, et al. Variability of vaginal pH determination by patients and clinicians. J Am Board Fam Med 2006;19:368.
19. Caillouette JC, Sharp CF Jr, Zimmerman GJ, Roy S. Vaginal pH as a marker for bacterial pathogens and menopausal status. Am J Obstet Gynecol 1997;176:1270.